Recordati Industria Chimica e Farmaceutica SPA (GB:0KBS)
LSE:0KBS
Total Valuation
Recordati Industria Chimica e Farmaceutica SPA has a market cap or net worth of €10.05B. The enterprise value is €9.56B.
Market Cap€10.05B
Enterprise Value€9.56B
Share Statistics
Recordati Industria Chimica e Farmaceutica SPA has 209,125,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding209,125,150
Owned by Insiders0.14%
Owned by Institutions―
Financial Efficiency
Recordati Industria Chimica e Farmaceutica SPA’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 13.01%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)13.01%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee571.70K
Profits Per Employee96.86K
Employee Count4,580
Asset Turnover0.50
Inventory Turnover1.54
Valuation Ratios
The current PE Ratio of Recordati Industria Chimica e Farmaceutica SPA is 22.5. Recordati Industria Chimica e Farmaceutica SPA’s PEG ratio is 3.24.
PE Ratio22.5
PS Ratio3.81
PB Ratio5.20
Price to Fair Value5.20
Price to FCF19.49
Price to Operating Cash Flow16.77
PEG Ratio3.24
Income Statement
In the last 12 months, Recordati Industria Chimica e Farmaceutica SPA had revenue of 2.62B and earned 443.62M in profits. Earnings per share was 2.16.
Revenue2.62B
Gross Profit1.79B
Operating Income719.74M
Pretax Income581.27M
Net Income443.62M
EBITDA887.00M
Earnings Per Share (EPS)2.16
Cash Flow
In the last 12 months, operating cash flow was 596.90M and capital expenditures -85.12M, giving a free cash flow of 511.77M billion.
Operating Cash Flow596.90M
Free Cash Flow511.77M
Free Cash Flow per Share2.45
Dividends & Yields
Recordati Industria Chimica e Farmaceutica SPA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.83
52-Week Price Change7.99%
50-Day Moving Average47.33
200-Day Moving Average49.94
Relative Strength Index (RSI)63.36
Average Volume (3m)7.60K
Important Dates
Recordati Industria Chimica e Farmaceutica SPA upcoming earnings date is May 12, 2026, TBA (Confirmed).
Last Earnings DateFeb 17, 2026
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
Recordati Industria Chimica e Farmaceutica SPA as a current ratio of 1.59, with Debt / Equity ratio of 1.24%
Current Ratio1.59
Quick Ratio1.08
Debt to Market Cap<0.01
Net Debt to EBITDA-0.46
Interest Coverage Ratio7.25
Taxes
In the past 12 months, Recordati Industria Chimica e Farmaceutica SPA has paid 137.65M in taxes.
Income Tax137.65M
Effective Tax Rate0.24
Enterprise Valuation
Recordati Industria Chimica e Farmaceutica SPA EV to EBITDA ratio is 10.79, with an EV/FCF ratio of 18.70.
EV to Sales3.65
EV to EBITDA10.79
EV to Free Cash Flow18.70
EV to Operating Cash Flow16.03
Balance Sheet
Recordati Industria Chimica e Farmaceutica SPA has €428.82M in cash and marketable securities with €23.85M in debt, giving a net cash position of €404.98M billion.
Cash & Marketable Securities€428.82M
Total Debt€23.85M
Net Cash€404.98M
Net Cash Per Share€1.94
Tangible Book Value Per Share-€6.18
Margins
Gross margin is 68.27%, with operating margin of 27.49%, and net profit margin of 16.94%.
Gross Margin68.27%
Operating Margin27.49%
Pretax Margin22.20%
Net Profit Margin16.94%
EBITDA Margin33.88%
EBIT Margin25.99%
Analyst Forecast
The average price target for Recordati Industria Chimica e Farmaceutica SPA is €53.83, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€53.83
Price Target Upside10.04% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―